ReviewBriefings in bioinformatics2025
Out of distribution learning in bioinformatics: advancements and challenges.
Review in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- TMEDRP: decoding tumor-intrinsic and microenvironmental signatures for clinical drug response prediction.Bioinformatics (Oxford, England) · 2026Article
- LoMuS: low-rank adaptation with sequence multi-representation improves protein stability prediction.Bioinformatics (Oxford, England) · 2026Article
- CancerSubtyper: a deep learning framework for cancer subtyping through DNA methylation data.Epigenetics & chromatin · 2026Article
- From Prediction to Creation: Generative Plant Design.Plants (Basel, Switzerland) · 2026Review
- Graph transformer for ancient ancestry inference.bioRxiv : the preprint server for biology · 2026Article
- Benchmarking deep learning models for predicting anticancer drug potency (ICCommunications chemistry · 2026Article
- Construction of a diagnostic model and identification of effect genes for diabetic kidney disease with concurrent vascular calcification based on bioinformatics and multiple machine learning approaches.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In the dynamic and complex field of bioinformatics, the development of machine learning models capable of accurately predicting and interpreting genomic data underpins many critical applications, from disease diagnosis to drug discovery. Traditional machine learning models, however, often fail when facing with out-of-distribution (OOD) samples that deviate from their training data, leading to significant performance degradation. This review paper delves into the realm of OOD learning within bioinformatics, highlighting its crucial role in enhancing model generalization and reliability across varied genomic datasets. We provide a comprehensive overview of recent advancements in OOD learning applications, detection techniques, and the integration of foundation models. The discussion extends to various bioinformatics sub-disciplines, including drug discovery, single cell genomics, and polygenic risk score analysis, underscoring how OOD learning has facilitated notable breakthroughs in these areas. Through detailed examination of different model architectures and methods designed to address distribution shifts, we explore the potential of OOD learning to overcome the inherent limitations of standard machine learning models in bioinformatics. This review paper can be served as a valuable resource for bioinformatics researchers, offering a detailed exploration of OOD learning's transformative impact on understanding complex genomic data and its implications for human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.